Recently published research [1] provides new hope for a potential cure for the devastating cystic fibrosis disease. In the study, a research collaboration demonstrated how they corrected mutations that cause cystic fibrosis in cultured human stem cells using a CRISPR/Cas9 variant technique called prime editing to replace the ‘faulty’ piece of DNA with a healthy […]
Shimadzu, one of the world leaders in analytical instrumentation, has appointed Jürgen Semmler as the new managing director of its European organization from July 1, 2021. Previously, head of Shimadzu Deutschland, he succeeds Jürgen Kwass, who led Shimadzu Europa from 2003 to the present and is now retiring. Semmler and Kwass have both been affiliated […]
As a partner of the Fraunhofer Competence Network Quantum Computing, the German Cancer Research Center is planning to use the quantu m computer in Ehningen, Baden-Württemberg, to develop individually effective cancer treatment methods.
Medovate has successfully secured additional CE Mark approvals for its SAFIRA (SAFer Injection for Regional Anaesthesia) technology to include an NRFit syringe and a Palm Operator
Minaris Regenerative Medicine, a leading contract development and manufacturing organization for the cell and gene therapy industry, will be the commercial manufacturer in Europe for bluebird bio’s Skysona (elivaldogene autotemcel, formerly Lenti-D gene therapy), for the treatment of Early Cerebral Adrenoleukodystrophy (CALD).
DeepMind has partnered with the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory for the life sciences, to make the most complete and accurate database yet of predicted protein structure models for the human proteome.
Owen Mumford has been awarded a RoSPA (Royal Society for the Prevention of Accidents) gold health and safety award. The awarded is given to organisations that achieve exceptional control of risk with very low levels of error, harm and loss.
Siemens Healthineers has recently started offering its customers WeScan. WeScan is a new service that helps healthcare providers to perform magnetic resonance imaging (MRI) examinations if they lack qualified radiology staff. With the WeScan service, customers may seek access to a pool of skilled remote imaging technologists who help operate the MRI scanner using syngo […]
Personalized tumour treatments are expensive. This particularly applies to individual cancer therapies based on gene-modified T cells. Currently, they are produced manually or, at best, in a partially automated process. In a collaboration project “ProCell for Patient” two hospitals are currently working with Optima Pharma to develop an automated unit for the decentralized production of […]
The US FDA has granted Fast Track designation to APB-102, Apic Bio’s lead gene therapy candidate designed to treat SOD1 amyotrophic lateral sclerosis (ALS). Apic said they plan to commence a Phase 1/2 clinical trial in early 2022.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.